KIT Overexpression

CI-VAR-00003224Explore in graph →CIViC 3731

Curated evidence

Evidence by cancer (1 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–1 of 1 evidence items across 1 cancer context on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Malignant Digestive System Neoplasm1
KIT Overexpression	Imatinib	Predictive	D	Supports Resistance	2	submitted	EID10152 Imatinib-resistant GIST882IR cells were derived by treating mice inoculated with GIST882 with imatinib over 6 passages. Western blots showed increased KIT protein expression in GIST882IR cells compare… (full text at CIViC) PMID 26587973 · Lai et al., 2016 · Open in CIViC	civic

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.